Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IREN: Brain Insulin Resistance Index in Plasma Neuronal Exosomes
NCT06825663Not yet recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Mar 2025
- Primary completion
- Sep 2027
01
Overview
Open-label, single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Prognostic performance of insulin resistance indexes at 3 years. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06825663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06825663.